MEDICAL devices maker Bespak has withdrawn from bid talks with several unnamed suitors who made offers at a 'significant premium' to the current price but not sufficient to tempt it.
The shares were unchanged today at 342 1/2p. A multi-million pound contract to supply delivery devices for diabetics using Pfizer's innovative inhaled insulin is providing Bespak with sound earnings.